Latest Breaking News On - Tom weible - Page 1 : comparemela.com

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJon congletonTom weibleTanabe pharmaCatalys pacificExchange commissionElixir health public relationsDrug administrationMineralys therapeutics incUs centers for diseaseTherapeutics reports first quarterProvides corporateOngoing phaseMineralys therapeuticsChief executive officerClinical highlights

Mineralys Therapeutics Announces $120 Million Private Placement Financing

Mineralys Therapeutics Announces $120 Million Private Placement Financing
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesTom weibleCatalys pacificMineralys therapeutics incExchange commissionElixir health public relationsTherapeutics announcesPrivate placementVenrock healthcare capital partnersSamsara biocapitalSecurities actMineralys therapeuticsPrivate securities litigation reform act

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkCatalys pacificTom weibleJon congletonMineralys therapeutics incElixir health public relationsGuggenheim securitiesAnnual biotechnologyChief executive officer jon congletonAnnual biotechnology conferenceNew york cityInvestor relationsMineralys therapeutics

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

RADNOR, Pa., Jan. 29, 2024 Mineralys Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease and other.

United statesNew yorkTom weibleCatalys pacificJon congletonGlobenewswire incElixir health public relationsMineralys therapeutics incChief executive officerYork cityInvestor relationsMineralys therapeutics

Mineralys Therapeutics Appoints Minji Kim, Ph D as Chief Business Officer

RADNOR, Pa., Jan. 04, 2024 (GLOBE NEWSWIRE) Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused o.

South koreaSoult ukpyolsiUnited statesMinji kimTom weibleCatalys pacificTanabe pharmaJon congletonAdam levyMineralys therapeutics incBusiness development at curis incExchange commissionGlobal oncology business developmentHead of business developmentElixir health public relationsAlliance management at jounce therapeutics